C. Raybarman and S. Bhattacharjee, “Aerosolized type II transmembrane serine protease 2 inhibitor to combat COVID-19: a proposal”, Int J Contemp Pediatr, vol. 8, no. 12, pp. 1996–1997, Nov. 2021.